Updated:
Kinnate Biopharma Inc.
Kinnate Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001797768, and its reported industry...
Overview
Kinnate Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001797768, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-28, it reported net income of USD -112,649,000; total assets of USD 173,605,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Kinnate Biopharma Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001797768
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2023USD | -$112.6M | $173.6M | $57.0M | -$100.0M | |
| FY2022USD | -$116.3M | $278.8M | $29.3M | -$89.0M | |
| FY2021USD | -$89.8M | $366.9M | $116.1M | -$71.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Kinnate Biopharma Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.